Financial Year |
March 31 2023 |
Monetary Funds |
9,838,268,698.17 |
Held-for-trading Financial Assets |
20,347,650.00 |
Notes Receivable |
2,452,704,905.43 |
Accounts Receivable |
3,214,614,752.45 |
Advances to Suppliers |
796,872,775.94 |
Other Receivables |
349,002,328.55 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
14,109,793.96 |
Inventories |
17,417,158,315.51 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
376,537,408.67 |
Total Current Assets |
39,602,181,489.13 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
1,179,975,401.07 |
Investment Properties |
-- |
Fixed Assetes |
59,961,095,353.24 |
Under-construction Projects |
2,359,883,263.83 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
2,547,545,425.09 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
654,374,953.18 |
Deferred Income Tax Assets |
374,353,307.68 |
Other Non-Current Assets |
37,981,491,981.53 |
Sub-Total of Non-Current Assets |
109,064,726,143.99 |
Total Assets |
148,666,907,633.12 |
Short-Term Loans |
7,489,585,388.61 |
Trading Financial liabilities |
-- |
Notes Payable |
12,470,658,055.03 |
Accounts Payable |
17,626,185,295.58 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
148,687,858.25 |
Taxes Payable |
696,337,300.34 |
Interest Payable |
-- |
Dividend Payable |
3,102,349.91 |
Other payables |
8,114,663,250.68 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
12,854,617,365.06 |
Other Current Liabilities |
6,057,936,038.44 |
Sub-Total of Current Liabilities |
70,282,175,404.29 |
Long-term Loans |
11,798,341,337.74 |
Bonds Payable |
1,931,321,872.05 |
Long-Term Accounts Payable |
2,448,787,204.75 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
1,549,124.81 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
16,820,250,810.57 |
Total Liabilities |
87,102,426,214.86 |
Paid-In Capital(Or Share Stock) |
45,585,032,648.00 |
Capital Surplus |
167,149,951.37 |
Surplus Reserve |
1,018,006,339.79 |
LESS:Treasury Stock |
199,999,951.75 |
Undistributed Profits |
5,855,253,735.66 |
Minority Stockholder's Interest |
8,758,901,977.44 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
52,805,579,440.82 |
Owner's Equity(Stockholder's Equity) |
61,564,481,418.26 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
148,666,907,633.12 |